Y-mAbs Therapeutics, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ARQT
|
Arcutis Biotherapeutics, Inc. | $10.04 | $838.13 M | -2.59 | 296 | $59.61 M |
 BCEL
|
Atreca, Inc. | $0.09 | $3.66 M | -0.04 | 90 | $770,000 |
 BDTX
|
Black Diamond Therapeutics, Inc. | $3.75 | $291.95 M | -3.13 | 54 | $0 |
 BLUE
|
bluebird bio, Inc. | $0.57 | $174.43 M | -1.44 | 375 | $29.50 M |
 CCCC
|
C4 Therapeutics, Inc. | $5.40 | $320.64 M | -1.97 | 145 | $20.76 M |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $14.10 | $1.12 B | -5.11 | 169 | $0 |
 ERAS
|
Erasca, Inc. | $2.54 | $647.94 M | -2.83 | 126 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $28.40 | $1.65 B | -11.47 | 97 | $0 |
 GBIO
|
Generation Bio Co. | $2.51 | $216.88 M | -1.28 | 174 | $5.90 M |
 ICVX
|
Icosavax, Inc. | $15.31 | $769.04 M | -6.96 | 60 | $582,000 |
 KRON
|
Kronos Bio, Inc. | $0.97 | $44.62 M | -0.37 | 58 | $6.29 M |
 LRMR
|
Larimar Therapeutics, Inc. | $6.62 | $611.84 M | -9.99 | 42 | $0 |
 MIRM
|
Mirum Pharmaceuticals, Inc. | $39.21 | $1.18 B | -6.7 | 294 | $186.37 M |
 MRSN
|
Mersana Therapeutics, Inc. | $2.12 | $261.85 M | -1.91 | 123 | $36.86 M |
 MRUS
|
Merus N.V. | $51.80 | $3.50 B | -19.38 | 172 | $43.95 M |
 PASG
|
Passage Bio, Inc. | $0.65 | $73.04 M | -0.77 | 58 | $0 |
 PCVX
|
Vaxcyte, Inc. | $111.39 | $7.72 B | -16.54 | 254 | $0 |
 RVMD
|
Revolution Medicines, Inc. | $47.31 | $6.66 B | -10.51 | 443 | $11.58 M |
 SNDX
|
Syndax Pharmaceuticals, Inc. | $18.82 | $1.66 B | -6.02 | 184 | $0 |
 STRO
|
Sutro Biopharma, Inc. | $3.66 | $303.46 M | -1.97 | 304 | $153.73 M |
 TCRR
|
TCR2 Therapeutics Inc. | $1.48 | $58.11 M | -0.35 | 58 | $0 |
 TVTX
|
Travere Therapeutics, Inc. | $15.23 | $542.80 M | -1.32 | 380 | $145.24 M |
 VECT
|
VectivBio Holding AG | $16.87 | $1.06 B | -8.03 | 0 | $27.34 M |
 ZNTL
|
Zentalis Pharmaceuticals, Inc. | $3.37 | $754.16 M | -3.26 | 124 | $0 |